SEC Filing Summary: Form 8-K
Business Context and Reporting Period
This Form 8-K is filed by AspenBio Pharma, Inc., a Colorado corporation, on April 29, 2008. The filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Note: The request metadata references "Riot Platforms, Inc.", but the source text explicitly identifies the registrant as AspenBio Pharma, Inc.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure notice rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed within the body of this filing. The document solely references the incorporation of a PowerPoint presentation.
Guidance, Outlook, and Disclosures
- Regulation FD Disclosure (Item 7.01): The company discloses information contained in a PowerPoint presentation (Exhibit 99.1) dated April 2008. This exhibit is incorporated by reference and is available on the company's website.
- Exhibits (Item 9.01): Exhibit 99.1 is listed as "Company information - 'Power Point Presentation' dated April 2008."
- Management Commentary: No direct commentary is provided in the text of the 8-K; all substantive information is deferred to the referenced exhibit.
Key Facts for Investor Verification
- Verify the content of the April 2008 PowerPoint presentation (Exhibit 99.1) to understand the actual disclosure made under Regulation FD.
- Confirm the registrant identity is AspenBio Pharma, Inc., not Riot Platforms, Inc., as the filing text explicitly names AspenBio.
- Check the company's website for the referenced presentation, as the 8-K itself contains no numerical data or strategic details.